• Info
  • Significant Ownership

Significant Ownership of Soleus Private Equity Fund III, L.P.

Signature - Title
/s/ Guy Levy - Guy Levy/Managing Member
Location
Greenwich, CT
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Soleus Private Equity Fund III, L.P..

Notify me when Soleus Private Equity Fund III, L.P. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Soleus Private Equity Fund III, L.P.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
CALC CALCIMEDICA, INC. Common Stock, par value $0.0001 per share 7.5% $3,309,118 1,075,856 Soleus Capital Management, L.P. 30 Sep 2025
IVVD INVIVYD, INC. Common Stock, par value $0.0001 per share 2.8% $19,425,992 -$7,916,008 7,708,727 -29% Soleus Capital Management, L.P. 31 Dec 2025
VSTM VERASTEM, INC. Common Stock 1.8% $6,541,375 935,819 Soleus Capital Management, L.P. 31 Mar 2025
IMUX IMMUNIC, INC. Common Stock, par value $0.0001 per share 1.6% $1,392,934 1,580,007 Soleus Capital Management, L.P. 30 Sep 2025

Schedules 13D/G Reported by Soleus Private Equity Fund III, L.P.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.